Navigation Links
Major variation in bladder cancer subtype trends highlights need for focused research
Date:1/4/2012

ancer cases. The majority of the patients (74%) were male and white (92%). Nearly two-thirds of the tumours (65%) were PTCC and 29% were TCC. The other 6% included squamous cell, adenocarcinoma and small cell carcinoma.
  • The overall age-adjusted incidence rates for bladder cancer fell by about 9% between 1973 and 2007 from 16.7 per 100,000 to 15.2. Similar trends were noted in both genders and racial groups.
  • However, significant differences emerged when the research team looked at the two main subtypes. While the age-adjusted rates for NPTCC fell by about 53%, from 7.9 per 100,000 in 1973 to 3.7 per 100,000 in 2007, PTCC increased by 56% from 6.8 to 10.6 per 100,000 over the same period. Similar trends were noted in both genders and racial groups and in different stages of the disease localised, regional and distant.
  • A dramatic increase in the incidence rates of grade four tumours was found between 1998 and 2007, with decreasing trends for grade one, two and three tumours. This is probably due to changes in the grading system introduced in 1998, but the lack of reduction in more aggressive bladder cancer is of great concern. Similar increases were observed for NPTCC and PTCC, genders, racial groups and different disease stages.

    "The striking differences in the trends between PTCC and NPTCC suggest that they may be two disease entitles with different causes" concludes Dr Zhang. "Recent survival analysis has also shown that survival rates are substantially higher for PTCC than NPTCC.

    "Despite this, no epidemiological studies have investigated the risk factors of these two subtypes separately. Our study suggests that future research must make clear distinctions between PTCC and NPTCC and not just treat them as subtypes of transitional cell carcinoma."


    '/>"/>

  • Contact: Annette Whibley
    annette.wizard@gmail.com
    Wiley-Blackwell
    Source:Eurekalert

    Page: 1 2

    Related medicine news :

    1. MP3 Players May Be Major Source of Hearing Loss
    2. Neuralstems NSI-189 trial in major depressive disorder receives FDA approval to advance to Phase Ib
    3. Majority of B.C. women take prescription drugs during pregnancy: UBC study
    4. Major cause of chronic kidney disease-related inflammation is identified
    5. Brain tsunamis are clue to helping victims of major head injuries
    6. Northern Ireland company makes major breakthrough in cancer treatment
    7. Major project to implement new treatments to boost kala-azar elimination strategies
    8. Earthquakes Put Millions of Lives, Major Cities at Risk
    9. How major signaling pathways are wired to our genome gives new insight into disease processes
    10. Policymakers should prepare for major uncertainties with Medicaid expansion
    11. Ghost Writing Persists in Major Medical Journals
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, a ... announced its only mission and research focus: Water Life Science®. In the current ... water evaporation is becoming dangerously accelerated. As a result of the global fresh ...
    (Date:9/4/2015)... , ... September 04, 2015 , ... Having access to ... has led to an increasing amount of unnecessary emergency room visits which affects hospitals’ ... taxes the country’s health bill. Fortunately, a solution to alleviate this problem has recently ...
    (Date:9/4/2015)... ... September 04, 2015 , ... ... Residence in South Glastonbury, Connecticut, has been selected for the Residential Award of ... energy efficiency and resiliency measures. Chosen from a highly competitive field of submissions, ...
    (Date:9/4/2015)... Charlotte, NC (PRWEB) , ... September 04, 2015 ... ... water filtration products, has a Labor Day offer that cannot be passed up. ... to stock up on necessary air and water filtration product replacements. Take advantage ...
    (Date:9/3/2015)... , ... September 04, 2015 , ... AlignLife of ... September. , "There are so many children and adults who don't have the ... Dr. Sara Mahalko-Leonhardt. "We love holding our annual Coat Drive to help those in ...
    Breaking Medicine News(10 mins):Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:AlignLife is Helping to Keep the Community Warm This Winter 2
    ... motor disease, , WEDNESDAY, March 10 (HealthDay News) -- ... smoke and Parkinson,s disease, researchers have found that smoking ... but smoking a large number of cigarettes a day ... had suggested that smokers have a lower risk of ...
    ... technological revolution, the "light fantastic" continues to impact people,s ... and performing intricate surgery. As the golden anniversary of ... 7th, Chemical & Engineering News (C&EN), ACS, weekly newsmagazine, ... exciting future of this amazing invention. C&EN ...
    ... ... HBS Alumnus Recognized for PrescriptionDrugs.com Business Plan , ... Boston, MA (PRWEB) March 11, 2010 -- A week ... their first ever HBS Alumni New Venture Contest . PrescriptionDrugs.com co-founder Mike “Zappy” ...
    ... A clinical research trial of a new treatment to ... safety stage, according to the UC Irvine neurologist who led ... no ill effects after the sequential administration of growth factors ... brain. All new drug treatments must pass this safety stage ...
    ... ... ... ... ...
    ... ... ... ... ...
    Cached Medicine News:Health News:Longtime Smokers May Find Protection From Parkinson's 2Health News:PrescriptionDrugs.com and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest 2Health News:PrescriptionDrugs.com and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest 3Health News:New Consumer Era Places Retailers at the Forefront of Participating in Shoppers' Health 2Health News:New Consumer Era Places Retailers at the Forefront of Participating in Shoppers' Health 3Health News:New Consumer Era Places Retailers at the Forefront of Participating in Shoppers' Health 4Health News:Visionworks(R) Provides Eye Care For Pittsburgh's Smiling Irish Eyes 2Health News:Visionworks(R) Provides Eye Care For Pittsburgh's Smiling Irish Eyes 3
    (Date:9/4/2015)... LONDON , September 4, 2015 ... HCM) today announces that Hutchison MediPharma Limited ("HMP"), ... endpoint in the second proof-of-concept ("POC") trial of ... lung cancer ("NSCLC") in China ... clearly succeeded in meeting the primary efficacy endpoint ...
    (Date:9/3/2015)... -- Report Details Ovarian Cancer Therapies ... and Emerging Opportunities What,s the future for treating ... forecasts those pharmaceutical revenues. There you find outlooks ... explore trends, results, treatments, R&D, and opportunities, seeing ... to 2025 at overall world market, submarket, product ...
    (Date:9/3/2015)... NEW YORK , Sept. 3, 2015 ... – Your New Guide to that Market, its R&D and ... want to assess the future of cancer-treating medicines? Visiongain,s new ... helping you stay ahead. There you discover financial data, R&D ... In our analysis you see forecasted sales ...
    Breaking Medicine Technology:Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7
    ... Jan. 30 Tigris Pharmaceuticals,Inc., a privately held ... ascending dose clinical study of aminoflavone,pro-drug (AFP-464) for ... dosed,in December 2007 and enrollment is ongoing., ... determine the dose limiting,toxicity (DLT) and maximum tolerated ...
    ... Product Urokinase and Evaluates Strategic ... Development Program, TUCSON, Ariz. Jan. 30 ImaRx ... will emphasize growing the,market for urokinase in contrast to ... additional value-creating opportunities for,urokinase was made possible by the ...
    Cached Medicine Technology:Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors 2Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors 3ImaRx Therapeutics Transitions Business Strategy 2ImaRx Therapeutics Transitions Business Strategy 3ImaRx Therapeutics Transitions Business Strategy 4ImaRx Therapeutics Transitions Business Strategy 5
    ... The Classic is a ... designed for use by people ... the easy-to-use picture control selector, ... materials in high-contrast black text ...
    ... magnifier (model CLCM) was designed especially for ... to see objects at a distance as well ... camera design allows viewing at near, intermediate and ... between near and distant viewing. With its included ...
    ... Maxport is a powerful magnifier that helps the partially ... of a hand magnifier attached to a pair of ... is no need for a TV set. The display ... images on a book, a can of food, a ...
    ... electronic magnification system. It was designed with ... patient in mind. PVA contains many new ... you to see your face to shave ... pixel full color camera. It connects easily ...
    Medicine Products: